(Australia-NewsWire.Com, December 23, 2016 ) According to the report Hormone Replacement Therapy, published by Market Data Forecast, the global market is projected to reach USD 22.31 billion by 2021, at a CAGR of 7.21% from 2016 to 2021. Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed.
Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of global hormone replacement therapy market. Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates the global HRT market. The largest consumers of estrogen replacement therapy are post-menopausal women.
North America dominated the market, where the majority of the contribution was from the USA owing to the well-established healthcare system. While, the market in the APAC region is expected to witness a rapid growth during the forecast period.
The Hormone Replacement Therapy Market is segmented as following: Based on Hormone Type: Estrogen Replacement Therapy Growth Hormone Replacement Therapy Thyroid Replacement Therapy Others
Based on Route of Administration Oral Parenteral Transdermal Others
Geographical Segmentation: North America Hormone Replacement Therapy Market Europe Hormone Replacement Therapy Market Asia-Pacific Hormone Replacement Therapy Market Latin America Hormone Replacement Therapy Market Middle-East & Africa Hormone Replacement Therapy Market
The major companies operating in the hormone replacement industry are Abbott Laboratories (U.S.), Novartis (Switzerland), Pfizer (U.S.), Mylan Laboratories (U.S.), Amgen (U.S.), Merck & Co. (U.S.), Bayer (Germany), Eli Lily (U.S.), Novo Nordisk (Denmark), Wyeth (U.S.), F. Hoffmann-La Roche (Switzerland), and Hisamitsu Pharmaceutical Co. Inc. (Japan).
The Hormone Replacement Therapy Market study offers the following deliverables: Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in Therapeutics Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.